- Home
- CDXS vs ACV Comparison
CDXS vs ACV Comparison
Compare CDXS & ACV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- ACV
- Stock Information
- Founded
- CDXS 2002
- ACV 2015
- Country
- CDXS United States
- ACV United States
- Employees
- CDXS N/A
- ACV N/A
- Industry
- CDXS Major Chemicals
- ACV Finance/Investors Services
- Sector
- CDXS Industrials
- ACV Finance
- Exchange
- CDXS Nasdaq
- ACV Nasdaq
- Market Cap
- CDXS 230.3M
- ACV 233.8M
- IPO Year
- CDXS 2010
- ACV N/A
- Fundamental
- Price
- CDXS $2.81
- ACV $19.83
- Analyst Decision
- CDXS Buy
- ACV
- Analyst Count
- CDXS 2
- ACV 0
- Target Price
- CDXS $11.00
- ACV N/A
- AVG Volume (30 Days)
- CDXS 1.1M
- ACV 38.8K
- Earning Date
- CDXS 05-01-2025
- ACV 01-01-0001
- Dividend Yield
- CDXS N/A
- ACV 9.20%
- EPS Growth
- CDXS N/A
- ACV N/A
- EPS
- CDXS N/A
- ACV N/A
- Revenue
- CDXS $59,345,000.00
- ACV N/A
- Revenue This Year
- CDXS $14.56
- ACV N/A
- Revenue Next Year
- CDXS $21.41
- ACV N/A
- P/E Ratio
- CDXS N/A
- ACV N/A
- Revenue Growth
- CDXS N/A
- ACV N/A
- 52 Week Low
- CDXS $2.43
- ACV $16.82
- 52 Week High
- CDXS $6.08
- ACV $23.74
- Technical
- Relative Strength Index (RSI)
- CDXS 42.35
- ACV 31.15
- Support Level
- CDXS $2.43
- ACV $20.20
- Resistance Level
- CDXS $3.04
- ACV $20.99
- Average True Range (ATR)
- CDXS 0.22
- ACV 0.44
- MACD
- CDXS 0.08
- ACV 0.05
- Stochastic Oscillator
- CDXS 51.35
- ACV 4.92
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest
Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. It seeks to achieve its investment objective by investing in a combination of convertible securities, debt and other income-producing instruments and common stocks and other equity securities.